Show Health and Fitness Publications

Wed, March 21, 2012

[ Wed, Mar 21st 2012 ] - Market Wire

Community Health Systems, Inc. Prevails in Tenet Litigation

[ Wed, Mar 21st 2012 ] - Market Wire

Stellar Pharmaceuticals Inc. Announces Correction .. onference Call Access Number Dated March 19, 2012

[ Wed, Mar 21st 2012 ] - Market Wire

Gentiva Health Services Updates Presentation Time .. al High Yield Bond and Syndicated Loan Conference

[ Wed, Mar 21st 2012 ] - Market Wire

3SBio Inc. Announces Changes to its Board of Directors

[ Wed, Mar 21st 2012 ] - Market Wire

Ronald L. Chez Files Amended Repligen 13D Urging .. ositive Director Action on Behalf of Shareholders

[ Wed, Mar 21st 2012 ] - Market Wire

Teva Pharmaceutical Industries Ltd. to Transfer Listing to NYSE

[ Wed, Mar 21st 2012 ] - Market Wire

Data on ELIQUIS (apixaban) for the Prevention of .. to Be Presented at American College of Cardiolog

[ Wed, Mar 21st 2012 ] - Market Wire

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

[ Wed, Mar 21st 2012 ] - Market Wire

VistaGen Therapeutics Enters Strategic Drug Screening Collaboration With Vala Sciences

[ Wed, Mar 21st 2012 ] - Market Wire

RevNutrition.com to Carry MedPodium Nutra-Apps Brand

[ Wed, Mar 21st 2012 ] - Market Wire

Response Genetics, Inc. to Release Fourth Quarter .. Results and Host Conference Call on March 27, 20

[ Wed, Mar 21st 2012 ] - Market Wire

Abiomed Appoints Susan Vissers Lisa as Senior Dir .. r of Investor Relations and Corporate Development

[ Wed, Mar 21st 2012 ] - Market Wire

Paladin Labs Announces Canadian Approval for Oralair(TM)

[ Wed, Mar 21st 2012 ] - Market Wire

iBio Announces Successful Completion of H1N1 Influenza Vaccine Phase 1 Clinical Trial

[ Wed, Mar 21st 2012 ] - Market Wire

Acura Pharmaceuticals to Present at the Needham Healthcare Conference on April 3, 2012

[ Wed, Mar 21st 2012 ] - Market Wire

Implant Sciences Receives Patent for Narcotics and Explosives Particle Removal System

[ Wed, Mar 21st 2012 ] - Market Wire

Bioline Receives Clearance from TGA for the Comme .. the New Molecular Test illumigene Group B Strepto

[ Wed, Mar 21st 2012 ] - Market Wire

Community Health Systems, Inc. Announces Early Te .. r Offer Results for Its 8?% Senior Notes Due 2015

[ Wed, Mar 21st 2012 ] - Market Wire

Astex Pharmaceuticals Announces March 27th Analyst and Investor Day Agenda

[ Wed, Mar 21st 2012 ] - Market Wire

Genomic Health Announces Presentation of Three On .. dies at the 8th European Breast Cancer Conference

Tue, March 20, 2012

[ Tue, Mar 20th 2012 ] - Market Wire

Centene Schedules 2012 First Quarter Financial Re .. ce Call and Announces 2012 Annual Meeting Webcast

[ Tue, Mar 20th 2012 ] - Market Wire

Cardium Initiates Generx Phase 3 Clinical Registration Study

[ Tue, Mar 20th 2012 ] - Market Wire

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

[ Tue, Mar 20th 2012 ] - Market Wire

WESTMED Medical Group Launches Accountable Care O .. in Collaboration with UnitedHealthcare and Optum

[ Tue, Mar 20th 2012 ] - Market Wire

Study Published in International Journal of Oncol .. RNAs to Determine Risk of Recurrence in Colorecta

[ Tue, Mar 20th 2012 ] - Market Wire

GencaroTM Atrial Fibrillation Data Selected for P .. ge of Cardiology 61st Annual Scientific Session &

[ Tue, Mar 20th 2012 ] - Market Wire

International Stem Cell Corporation Announces 2011 Financial Results

[ Tue, Mar 20th 2012 ] - Market Wire

BioSante Pharmaceuticals Announces Positive Pill-Plusa" Data Presentation

[ Tue, Mar 20th 2012 ] - Market Wire

Aeterna Zentaris to Announce Fourth Quarter and F .. Financial and Operating Results on March 27, 2012

[ Tue, Mar 20th 2012 ] - Market Wire

Mylan One of First to Launch Generic Version of Boniva

[ Tue, Mar 20th 2012 ] - Market Wire

Covidien Announces FDA 510(k) Clearance of Nellcora" Respiration Rate Software

[ Tue, Mar 20th 2012 ] - Market Wire

Covidien annuncia approvazione FDA 510(k) del software Nellcora" Respiration Rate

[ Tue, Mar 20th 2012 ] - Market Wire

Covidien gibt FDA-510(k)-Zulassung der Nellcora" Respiration Rate Software bekannt

[ Tue, Mar 20th 2012 ] - Market Wire

Bioline Celebrates 20 Years of Service to Life Science

[ Tue, Mar 20th 2012 ] - Market Wire

Covidien annonce l'approbation 510(k) de la FDA r .. urveillance de la frquence respiratoire Nellcora"

[ Tue, Mar 20th 2012 ] - Market Wire

Enzo Biochem Announces Expanded Distribution Agreement with Japanas Cosmo Bio

[ Tue, Mar 20th 2012 ] - Market Wire

LCA-Vision to Present at the Maxim Group Growth Conference

[ Tue, Mar 20th 2012 ] - Market Wire

Pacira Pharmaceuticals, Inc. Announces Timing for .. 011 Financial Results Webcast and Conference Call

[ Tue, Mar 20th 2012 ] - Market Wire

Delcath Announces First Commercial CHEMOSAT Order in Europe

[ Tue, Mar 20th 2012 ] - Market Wire

Heptares Grants Shire an Exclusive Worldwide Lice .. mercialise Novel Drug Candidate for CNS Disorders

Mon, March 19, 2012

[ Mon, Mar 19th 2012 ] - Market Wire

OPKO Health Expands Collaboration with Arctic Partners

[ Mon, Mar 19th 2012 ] - Market Wire

Political Activist Filmmaker Kevin Booth Retained .. by Cannabis Science to Film Specialty Documentary

[ Mon, Mar 19th 2012 ] - Market Wire

MabCure Announces Agreement with the City Univers .. vanced Technology to Validate and Evaluate Its Mo

[ Mon, Mar 19th 2012 ] - Market Wire

Amarantus BioSciences Reports Addition of New Scientific Articles to MANF Publications List

[ Mon, Mar 19th 2012 ] - Market Wire

MMRGlobal Plans on Announcing Increased Revenues on March 30

[ Mon, Mar 19th 2012 ] - Market Wire

Rosetta Genomics to Present Multiple Poster Prese .. Meeting of the United States and Canadian Academy

[ Mon, Mar 19th 2012 ] - Market Wire

Stellar to Hold Conference Call re Health Canada .. of CAMBIA(R) for the Treatment of Acute Migraines

[ Mon, Mar 19th 2012 ] - Market Wire

Life Technologies Launches GeneArt Precision TALs

[ Mon, Mar 19th 2012 ] - Market Wire

Solta Medical to Present at Upcoming Investor Conferences

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien annonce la signature daun accord dfinitif en vue de laacquisition de superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien anuncia acordo final para adquirir a superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

New Study Finds Cambridge Heartas MTWA Test to Be a Powerful Predictor of Sudden Cardiac Arrest

[ Mon, Mar 19th 2012 ] - Market Wire

Implant Sciences Appoints Dr. Bill McGann as Chief Operating Officer

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien Announces Definitive Agreement to Acquire superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

Covidien annuncia accordo definitivo per acquisire superDimension, Ltd.

[ Mon, Mar 19th 2012 ] - Market Wire

Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain

[ Mon, Mar 19th 2012 ] - Market Wire

Illumina Files Definitive Proxy Materials and Sends Letter to Stockholders

[ Mon, Mar 19th 2012 ] - Market Wire

Co-Principal Investigator for OncoSec's Phase II .. o Speak at 70th Annual American Academy of Dermat

[ Mon, Mar 19th 2012 ] - Market Wire

Cytori Breast Reconstruction Cell Therapy Trial Results Published

Sun, March 18, 2012

[ Sun, Mar 18th 2012 ] - Market Wire

STATS ChipPAC Provides Updated Outlook for First Quarter 2012

Fri, March 16, 2012

[ Fri, Mar 16th 2012 ] - Market Wire

Kensey Nash Announces Mediated Settlement With St .. License Disputes and 5 Year Extension and Expansi

[ Fri, Mar 16th 2012 ] - Market Wire

Cubist Opens Expanded Research and Development Facility

[ Fri, Mar 16th 2012 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Columbia Laboratories Inc. o

[ Fri, Mar 16th 2012 ] - Market Wire

HeartWare Receives 54-Patient Allotment From FDA .. ol for Pivotal U.S. Bridge-to-Transplant Clinical

[ Fri, Mar 16th 2012 ] - Market Wire

Health Canada Approves CAMBIA(R) for the Treatment of Acute Migraine

[ Fri, Mar 16th 2012 ] - Market Wire

OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering

[ Fri, Mar 16th 2012 ] - Market Wire

HCA Named to Ethisphereas 2012 aWorldas Most Ethical Companiesa

[ Fri, Mar 16th 2012 ] - Market Wire

Cynosure to Present at 2012 Maxim Group Growth Conference

[ Fri, Mar 16th 2012 ] - Market Wire

Analytical Reports on Teva Pharmaceutical Industr .. tories Inc. - Drug Manufacturers Flexing Pipeline

[ Fri, Mar 16th 2012 ] - Market Wire

Equity Research on Unitedhealth Group Inc. and CIGNA Corp. - Health Care and the Economic Recovery

[ Fri, Mar 16th 2012 ] - Market Wire

ImmunoCellular Appoints Dr. Richard Chin To Board of Directors

[ Fri, Mar 16th 2012 ] - Market Wire

FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850

[ Fri, Mar 16th 2012 ] - Market Wire

Echo Therapeutics, Inc. Announces 2011 Financial Results

[ Fri, Mar 16th 2012 ] - Market Wire

Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery

[ Fri, Mar 16th 2012 ] - Market Wire

American Oriental Bioengineering Inc. Announces D .. Filing of its Annual Report on Form 10-K for 2011

[ Fri, Mar 16th 2012 ] - Market Wire

Threshold Pharmaceuticals' TH-302 Receives Orphan .. pean Union for the Treatment of Soft Tissue Sarco

[ Fri, Mar 16th 2012 ] - Market Wire

Cambridge Heart Announces Microvolt T-Wave Alternans Receives Reimbursement Coverage in Japan

[ Fri, Mar 16th 2012 ] - Market Wire

Repligen Reports Financial Results for the Quarte .. nd Nine-Month Fiscal Year Ended December 31, 2011

[ Fri, Mar 16th 2012 ] - Market Wire

First Patient Enrolled Into European Registry for .. Stimulation in Patients With Refractory Epilepsy

Thu, March 15, 2012

[ Thu, Mar 15th 2012 ] - Market Wire

Genomma Lab Internacional to Nominate Slate of Fi .. Election at Prestige Brandsa 2012 Annual Meeting

[ Thu, Mar 15th 2012 ] - Market Wire

Anthera Provides Corporate Update on Recent Activities

[ Thu, Mar 15th 2012 ] - Market Wire

AdCare Health Systems Acquires Two Skilled Nursing Facilities in Oklahoma

[ Thu, Mar 15th 2012 ] - Market Wire

Leisureworld Announces March Dividend

[ Thu, Mar 15th 2012 ] - Market Wire

Verisante Technology, Inc. Announces Exclusive Di .. Agreement With Clarion Medical Technologies Inc.

[ Thu, Mar 15th 2012 ] - Market Wire

MethylGene Reports Fourth Quarter and Full Year 2011 Financial Results

[ Thu, Mar 15th 2012 ] - Market Wire

Amgen Announces 2012 Second Quarter Dividend

[ Thu, Mar 15th 2012 ] - Market Wire

Cytomedix Announces Publication in American Heart .. e Phase I Clinical Data Using ALD-201 to Treat Is

[ Thu, Mar 15th 2012 ] - Market Wire

Cynosure Introduces Enhanced Elite+ and Apogee+ Workstations for Faster Aesthetic Treatments

[ Thu, Mar 15th 2012 ] - Market Wire

Celsion Reports Year End 2011 Financial Results and Provides Business Update

[ Thu, Mar 15th 2012 ] - Market Wire

GenVec Reports Fourth Quarter and 2011 Year-End Financial Results

[ Thu, Mar 15th 2012 ] - Market Wire

Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment

[ Thu, Mar 15th 2012 ] - Market Wire

United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents

[ Thu, Mar 15th 2012 ] - Market Wire

Amedisys Scores 19% Above National Average on Treatment Goals Met at Home

[ Thu, Mar 15th 2012 ] - Market Wire

DaVita Clinics Give $67,000 to Ohio Charities

[ Thu, Mar 15th 2012 ] - Market Wire

Delcath Announces Agreement With Institut Gustave .. nch of Hepatic CHEMOSAT Delivery System in France

[ Thu, Mar 15th 2012 ] - Market Wire

InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update

[ Thu, Mar 15th 2012 ] - Market Wire

Abbott Announces Patient Enrollment in Two Phase .. ab) for Moderate to Severe Hidradenitis Suppurati

[ Thu, Mar 15th 2012 ] - Market Wire

PAREXEL Global Survey Results Identify Top Concer .. iopharma Industry in Achieving Commercial Success

Wed, March 14, 2012

[ Wed, Mar 14th 2012 ] - Market Wire

Flamel Technologies Announces Acquisition of clat Pharmaceuticals

[ Wed, Mar 14th 2012 ] - Market Wire

Teva Announces Launch of Generic Lexapro in the U .. ; Awarded 180-Day Period of Marketing Exclusivity

[ Wed, Mar 14th 2012 ] - Market Wire

Guided Therapeutics to Report Q4 2011 Results and Hold Conference Call

[ Wed, Mar 14th 2012 ] - Market Wire

Securities Lawyers Seeking More Money, Informatio .. es Stockholders in Buyout, Announces Goldfarb LLP

[ Wed, Mar 14th 2012 ] - Market Wire

Goldfarb LLP Securities Lawyers Seek More Money, .. formation for Shareholders in Zoll Medical Buyout

[ Wed, Mar 14th 2012 ] - Market Wire

Biogen Idec Takes Option to MAKScientific MS Program

[ Wed, Mar 14th 2012 ] - Market Wire

Generex Subsidiary Antigen Express Announces Publ .. its Proprietary Therapeutic Vaccine Technology in

[ Wed, Mar 14th 2012 ] - Market Wire

Threshold Pharmaceuticals Doses First Patient in .. nical Trial Evaluating TH-302 in Multiple Myeloma

[ Wed, Mar 14th 2012 ] - Market Wire

Trimel Pharmaceuticals Corporation Provides Update on Operational Leadership

[ Wed, Mar 14th 2012 ] - Market Wire

Verastem, Inc. Reports Year-End 2011 Financial Results

[ Wed, Mar 14th 2012 ] - Market Wire

Covidien meldt resultaten van 2012 jaarlijkse algemene vergadering

[ Wed, Mar 14th 2012 ] - Market Wire

DaVita Thanks its 1,500 Dietitianson Registered Dietitian Day

[ Wed, Mar 14th 2012 ] - Market Wire

Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation

[ Wed, Mar 14th 2012 ] - Market Wire

Alnylam Retains Key Claims for Kinesin Spindle Pr .. ein (KSP) RNAi Patent in Interference Proceedings

[ Wed, Mar 14th 2012 ] - Market Wire

Synthetic Biologics Announces Completion of Enrol .. l Trial of Oral Trimestaa" for Multiple Sclerosis

[ Wed, Mar 14th 2012 ] - Market Wire

Marina Biotech and ProNAi Therapeutics Announce L .. nt for the Development of DNAi-Based Therapeutics

[ Wed, Mar 14th 2012 ] - Market Wire

OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial

[ Wed, Mar 14th 2012 ] - Market Wire

Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data

[ Wed, Mar 14th 2012 ] - Market Wire

Perceptive Informatics Global Survey Results Show .. ption of Web-based RTSM Systems by Clinical Sites

Tue, March 13, 2012

[ Tue, Mar 13th 2012 ] - Market Wire

Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share

[ Tue, Mar 13th 2012 ] - Market Wire

ActiveCare Acquires 4G Biometrics in Move to Addr .. ing Needs of Diabetic Patients and Their Families

[ Tue, Mar 13th 2012 ] - Market Wire

SciClone Reports Financial Results for the Fourth Quarter and Year 2011 and Outlook for 2012

[ Tue, Mar 13th 2012 ] - Market Wire

VELscope Vx(R) Approved for Use by AppleWhite Dental Partners

[ Tue, Mar 13th 2012 ] - Market Wire

Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan

[ Tue, Mar 13th 2012 ] - Market Wire

Endo Files Amended Citizen Petition Seeking Publi .. Safety and Efficacy Issues Prior to Approval of a

[ Tue, Mar 13th 2012 ] - Market Wire

NuPathe to Report Fourth Quarter and Full Year 20 .. d Hold Conference Call on Tuesday, March 20, 2012

[ Tue, Mar 13th 2012 ] - Market Wire

Comprehensive Care Corporation Celebrates 43rd Anniversary

[ Tue, Mar 13th 2012 ] - Market Wire

Enzo Biochemas Clinical Laboratory Applies for NY .. oval for First Assay Based on Its AmpiProbea" Amp

[ Tue, Mar 13th 2012 ] - Market Wire

Codexis to Present at Sidotias Emerging Growth Institutional Investor Forum

[ Tue, Mar 13th 2012 ] - Market Wire

Columbia Laboratories Hires Cowen and Company to .. st in Evaluating Potential Strategic Transactions

[ Tue, Mar 13th 2012 ] - Market Wire

OncoSec President and CEO Contributes to Today's Medical Developments

[ Tue, Mar 13th 2012 ] - Market Wire

Aeolus to Present at Roth Capital Partners' 24th Annual Growth Stock Conference

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific vor der bernahme von Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific comprar Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Acquisition de Cameron Health, Inc. par Boston Scientific

[ Tue, Mar 13th 2012 ] - Market Wire

Boston Scientific annuncia l'acquisizione di Cameron Health, Inc.

[ Tue, Mar 13th 2012 ] - Market Wire

Inovio Pharmaceuticals' PENNVAX-B HIV Vaccine Dem .. ell Immune Responses in Therapeutic Vaccine Trial

[ Tue, Mar 13th 2012 ] - Market Wire

AstraZeneca Files Lawsuit against the FDA for Dec .. rding Quetiapine Product Labeling and Exclusivity

Mon, March 12, 2012

[ Mon, Mar 12th 2012 ] - Market Wire

Cannabis Science Confirms Target Indication for F .. eeting with the FDA with Its Team of FDA Speciali

[ Mon, Mar 12th 2012 ] - Market Wire

Syneron to Acquire Assets of TransPharma Medical Ltd.

[ Mon, Mar 12th 2012 ] - Market Wire

Lpath Prepares to Continue iSONEP Trials in August

[ Mon, Mar 12th 2012 ] - Market Wire

Pfizer and Bristol-Myers Squibb Look to Reshape Anticoagulant Market

[ Mon, Mar 12th 2012 ] - Market Wire

Equity Research on Mylan Inc. and Watson Pharmace .. Makers Continue to Capitalize on Expiring Patents

[ Mon, Mar 12th 2012 ] - Market Wire

American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy

[ Mon, Mar 12th 2012 ] - Market Wire

Enzon Reports Fourth-Quarter and Full-Year 2011 Results

[ Mon, Mar 12th 2012 ] - Market Wire

WaferGen Appoints Ivan Trifunovich President, CEO, and Director

[ Mon, Mar 12th 2012 ] - Market Wire

Infinity Appoints Two Experienced Industry Leaders to Its Board of Directors

[ Mon, Mar 12th 2012 ] - Market Wire

Zynex Acquires NeuroDyne Medical, Corp.

[ Mon, Mar 12th 2012 ] - Market Wire

International Stem Cell Corporation Completes $5 .. and Elects Jim Berglund to the Board of Directors

[ Mon, Mar 12th 2012 ] - Market Wire

ImmunoCellular Therapeutics Reports Manufacturing Process Data for ICT-107

[ Mon, Mar 12th 2012 ] - Market Wire

Threshold Pharmaceuticals' TH-302 to Be Featured .. Cancer Hosted by the New York Academy of Sciences

[ Mon, Mar 12th 2012 ] - Market Wire

ONSOLIS Relaunch Postponed Pending Product Modification

[ Mon, Mar 12th 2012 ] - Market Wire

Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy

[ Mon, Mar 12th 2012 ] - Market Wire

Teleflex Appoints Thomas E. Powell Senior Vice President & Chief Financial Officer

[ Mon, Mar 12th 2012 ] - Market Wire

PAREXEL Experts to Address Approaches to Accelera .. ase Development Decisions at ASCPT Annual Meeting

[ Mon, Mar 12th 2012 ] - Market Wire

Medisafe 1 Technologies Signs Marketing and Distribution Agreement with Health Product Carrier

[ Mon, Mar 12th 2012 ] - Market Wire

Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock

Sat, March 10, 2012

[ Sat, Mar 10th 2012 ] - Market Wire

Gegevens tonen aan dat Gilead';;s .. ferieur is aan op protease gebaseerd regime na 48

[ Sat, Mar 10th 2012 ] - Market Wire

I dati di un secondo importante studio di Fase II .. t del regime Quad di Gilead per il trattamento de

[ Sat, Mar 10th 2012 ] - Market Wire

Quad-HIV-Prparat von Gilead nach 48 Wochen nicht .. g auf Protease-Basis: Beleg durch Daten einer zwe

[ Sat, Mar 10th 2012 ] - Market Wire

Los datos muestran que el rgimen Quad de Gilead p .. rgimen basado en proteasa a las 48 semanas en un

[ Sat, Mar 10th 2012 ] - Market Wire

Gegevens tonen aan dat Gilead's Quad-regime voor .. protease gebaseerd regime na 48 weken, in tweede

[ Sat, Mar 10th 2012 ] - Market Wire

Tenet to Speak at the Barclays Capital Healthcare Conference on March 14th

[ Sat, Mar 10th 2012 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Lead Plain .. e In The Class Action Lawsuit Against TranS1 Inc.

Fri, March 9, 2012

[ Fri, Mar 09th 2012 ] - Market Wire

Edwards Lifesciences to Present at the 24th Annual ROTH Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Cynapsus Therapeutics Announces $1 Million Financing

[ Fri, Mar 09th 2012 ] - Market Wire

Patient Home Monitoring (PHM) Announces February .. s and Growth Figures, Change in Operation Executi

[ Fri, Mar 09th 2012 ] - Market Wire

The Law Firm of Levi amp;; Korsinsky, LLP .. anscend Services, Inc. in Connection with the Sal

[ Fri, Mar 09th 2012 ] - Market Wire

Titan Medical Inc. Files Prospectus Supplement for Unit Offering

[ Fri, Mar 09th 2012 ] - Market Wire

Regeneron Announces Change in Date for Presentati .. arclays Capital 2012 Global Healthcare Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Is Health Discovery Corporation Finally on the Verge of a Turnaround?

[ Fri, Mar 09th 2012 ] - Market Wire

Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin

[ Fri, Mar 09th 2012 ] - Market Wire

Cantel Medical Corp. to Present at the Sidoti amp .. nth Annual Emerging Growth Institutional Investor

[ Fri, Mar 09th 2012 ] - Market Wire

(NYSE Amex: DXR) Daxor Announces Filing of Two Ad .. onal Patents for Updated Automated Blood Analyzer

[ Fri, Mar 09th 2012 ] - Market Wire

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on PhotoMedex, Inc.

[ Fri, Mar 09th 2012 ] - Market Wire

Ardea Biosciences Reports Recent Accomplishments .. urth Quarter and Full-Year 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

BD to Present at the Barclays Capital Global Healthcare Conference

[ Fri, Mar 09th 2012 ] - Market Wire

Equity Research on Valeant Pharmaceuticals Intern .. n Corp. plc - Drug Delivery Companies Up and Down

[ Fri, Mar 09th 2012 ] - Market Wire

Haemonetics Sets Date for Investor/Analyst Meeting

[ Fri, Mar 09th 2012 ] - Market Wire

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results

[ Fri, Mar 09th 2012 ] - Market Wire

Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012

[ Fri, Mar 09th 2012 ] - Market Wire

Delcath Selects Quintiles to Support EU Launch of CHEMOSAT

Thu, March 8, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

BIOLASE Chief Executive Officer to Continue at Rate of $1.00 Annual Salary

[ Thu, Mar 08th 2012 ] - Market Wire

PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million

[ Thu, Mar 08th 2012 ] - Market Wire

OncoGenex Pharmaceuticals, Inc. Reports Financial .. and Year End 2011 and Provides Update on Clinical

[ Thu, Mar 08th 2012 ] - Market Wire

Sangamo Presents New Clinical Data at CROI 2012 D .. ive Effects of ZFN Therapeutic for "Functional Cu

[ Thu, Mar 08th 2012 ] - Market Wire

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance

[ Thu, Mar 08th 2012 ] - Market Wire

LED Dental Launches Second Step Laboratory Services in Canada

[ Thu, Mar 08th 2012 ] - Market Wire

Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[ Thu, Mar 08th 2012 ] - Market Wire

Boston Scientific Renews Agreement with Lumenis t .. ative Laser Products to Treat Urologic Conditions

[ Thu, Mar 08th 2012 ] - Market Wire

USANA Health Sciences Unveils New Charitable Foundation

[ Thu, Mar 08th 2012 ] - Market Wire

Amylin Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference

[ Thu, Mar 08th 2012 ] - Market Wire

MIT Agrees to $3.2 Million in Financing, Includin .. in Convertible Debentures and $1.2 Million in Deb

[ Thu, Mar 08th 2012 ] - Market Wire

Celsion Corporation to Hold Year-End 2011 Financi .. sults Conference Call on Thursday, March 15, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Palatin Technologies Completes Enrollment in Phas .. 2B Bremelanotide Female Sexual Dysfunction Trial

[ Thu, Mar 08th 2012 ] - Market Wire

Michael E. DeBakey VA Medical Center Initiates Ph .. ia with Aeterna Zentaris' Ghrelin Agonist, AEZS-1

[ Thu, Mar 08th 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference

[ Thu, Mar 08th 2012 ] - Market Wire

Implant Sciences Sells More QS-H150 Explosives Trace Detection Devices to Chinese Airports

[ Thu, Mar 08th 2012 ] - Market Wire

OncoSec to Evaluate Potential Predictive or Progn .. t of Solid Tumor Cancers Using OMS ElectroImmunot

[ Thu, Mar 08th 2012 ] - Market Wire

Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012

[ Thu, Mar 08th 2012 ] - Market Wire

Threshold Pharmaceuticals Reports Fourth Quarter .. d Year End 2011 Financial and Operational Results

Biogen Idec Takes Option to MAKScientific MS Program

_{//health-fitness.news-articles.net/content/2012/ .. ec-takes-option-to-makscientific-ms-program.html}
^{Published in Health and Fitness on Wednesday, March 14th 2012 at 7:30 GMT by Market Wire}

Biogen Idec Takes Option to MAKScientific MS Program -- BOSTON, March 14, 2012 /PRNewswire/ --

Biogen Idec Takes Option to MAKScientific MS Program

[ ]

BOSTON, March 14, 2012 /PRNewswire/ -- MAKScientific, LLC, a privately held company focused on the discovery of novel therapeutics modulating cannabinoid pathways, today announced that it has entered into an exclusive, worldwide option and collaboration agreement with Biogen Idec (NASDAQ: [ BIIB ]) to develop and commercialize drug candidates for the treatment of multiple sclerosis (MS) and other neurodegenerative diseases.

Under the agreement, Biogen Idec will receive an option for an exclusive license to select discovery-stage MAKScientific drug candidates for all indications worldwide. Upon Biogen Idec's exercise of the option, MAKScientific will be eligible to receive an exercise fee of up to $3 million and up to an additional $31 million in milestone payments associated with the clinical development of the drug candidates. In addition, MAKScientific will be eligible to receive royalties on net sales worldwide.

"We are very excited to initiate this collaboration with Biogen Idec," said Alexandros Makriyannis, PhD, Founder of MAKScientific. "We believe it will help advance our proprietary medicinal chemistry to the benefit of MS patients. As a global leader in MS research and development, Biogen Idec is the ideal partner for our discovery and development program."

About MAKScientific.

MAKScientific LLC, is a privately held, Massachusetts-based, discovery stage, life sciences company specializing in the identification and development of novel therapies exploiting cutting-edge cannabinoid receptor pathways for the treatment of pain, inflammatory disorders and MS.

SOURCE MAKScientific, LLC

[ Back to top ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire